Authors: Pepus Daunis-i-Estadella, Josep Puig, Max Wintermark, Javier Sánchez-González, Christian Federau, Angel Alberich-Bayarri, Kambiz Nael, Marco Essig, Salvador Pedraza, Gerard Blasco, Carles Biarnes, Rajan Jain
Source:
PLoS ONE
PloS one, vol. 11, no. 7, pp. e0158887
PLoS ONE, Vol 11, Iss 7, p e0158887 (2016)
Subject Terms: Ressonància magnètica, Magnetic resonance, Cervell -- Tumors, Brain -- Tumors, Gliomes, Gliomas, Research Article, Medicine and Health Sciences, Diagnostic Medicine, Diagnostic Radiology, Magnetic Resonance Imaging, Research and Analysis Methods, Imaging Techniques, Radiology and Imaging, Oncology, Cancers and Neoplasms, Blastomas, Glioblastoma Multiforme, Neurological Tumors, Neurology, Glioma, Cancer Treatment, Cancer Detection and Diagnosis, Physical Sciences, Chemistry, Chemical Physics, Mass Diffusivity, Physics, Biology and Life Sciences, Anatomy, Body Fluids, Blood, Physiology, Hematology, Blood Flow, Aged, Biomarkers/metabolism, Brain/diagnostic imaging, Brain/pathology, Brain Neoplasms/diagnostic imaging, Brain Neoplasms/mortality, Diffusion Magnetic Resonance Imaging, Female, Glioblastoma/diagnostic imaging, Glioblastoma/mortality, Humans, Image Processing, Computer-Assisted, Kaplan-Meier Estimate, Male, Middle Aged, Motion, Observer Variation, Perfusion, Prognosis, Proportional Hazards Models, Prospective Studies, Sensitivity and Specificity, Treatment Outcome, Multidisciplinary, Intravoxel incoherent motion, Nuclear medicine, business.industry, business, Brain tumor, medicine.disease, medicine, Biomarker (medicine), Hazard ratio, Magnetic resonance imaging, medicine.diagnostic_test, Proportional hazards model, Prospective cohort study, lcsh:Medicine, lcsh:R, lcsh:Science, lcsh:Q
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6229ace5f2ae93dbb9db3309aba4396
http://hdl.handle.net/2072/319617
Authors: Marie Louise Kimper-Karl, Marco Donia, Lars Bastholt, Inge Marie Svane, Katrine Lundby Høyer, Henrik Schmidt
Source:
Donia, M, Kimper-Karl, M L, Høyer, K L, Bastholt, L, Schmidt, H & Svane, I M 2017, ' The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials ', European Journal of Cancer, vol. 74, pp. 89-95 . https://doi.org/10.1016/j.ejca.2016.12.017
Donia, M, Kimper-Karl, M L, Høyer, K L, Bastholt, L, Schmidt, H & Svane, I M 2017, ' The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials ', European journal of cancer (Oxford, England : 1990), vol. 74, pp. 89-95 . https://doi.org/10.1016/j.ejca.2016.12.017
Subject Terms: Immunotherapy, Metastatic melanoma, Patient selection, Phase III trials, Real-world patients, Immunotherapy/methods, Humans, Middle Aged, Male, Incidence, Melanoma/mortality, Young Adult, Biological Factors/administration & dosage, Clinical Trials, Phase III as Topic, Neoplasm Metastasis, Aged, 80 and over, Adult, Female, Skin Neoplasms/mortality, Randomized Controlled Trials as Topic, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Denmark/epidemiology, Antibodies, Monoclonal, Humanized/administration & dosage, Adolescent, Aged, Brain Neoplasms/mortality, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Biological Factors, Brain Neoplasms, Denmark, Melanoma, Skin Neoplasms, Journal Article, Cancer Research, Oncology, Phase iii trials, medicine.medical_treatment, medicine, Surgery, medicine.medical_specialty, business.industry, business, Immune checkpoint inhibitors, Patient population, Ocular Melanoma, Overall survival, Poor prognosis, Internal medicine
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59fdae568f070a2ec06f1fec6f12192a
https://portal.findresearcher.sdu.dk/da/publications/e71f5ee7-0f4f-40b0-a4ac-51078b820950
Authors: Wick, Wolfgang, Gorlia, Thierry, Bady, Pierre, Platten, Michael, van den Bent, Martin J, Taphoorn, Martin J B, Steuve, Jonathan, Brandes, Alba A, Hamou, Marie-France, Wick, Antje, Kosch, Markus, Weller, Michael, Stupp, Roger, Roth, Patrick, Golfinopoulos, Vassilis, Frenel, Jean-Sebastien, Campone, Mario, Ricard, Damien, Marosi, Christine, Villa, Salvador, Weyerbrock, Astrid, Hopkins, Kirsten, Homicsko, Krisztian, Lhermitte, Benoit, Pesce, Gianfranco, Hegi, Monika E
Source:
Clinical Cancer Research
Wick, Wolfgang; Gorlia, Thierry; Bady, Pierre; Platten, Michael; van den Bent, Martin J; Taphoorn, Martin J B; Steuve, Jonathan; Brandes, Alba A; Hamou, Marie-France; Wick, Antje; Kosch, Markus; Weller, Michael; Stupp, Roger; Roth, Patrick; Golfinopoulos, Vassilis; Frenel, Jean-Sebastien; Campone, Mario; Ricard, Damien; Marosi, Christine; Villà, Salvador; Weyerbrock, Astrid; Hopkins, Kirsten; Homicsko, Krisztian; Lhermitte, Benoit; Pesce, Gianfranco; Hegi, Monika E (2016). Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research, 22(19):4797-4806.
Clinical Cancer Research, 22(19), 4797-4806
Clinical cancer research, vol. 22, no. 19, pp. 4797-4806
Clinical Cancer Research : An Official Journal of the American Association For Cancer Research 22(19) 4797-4806
Subject Terms: Clinic for Neurology, Clinic for Oncology and Hematology, 610 Medicine & health, Cancer Research, Oncology, Temsirolimus, medicine.drug, medicine, Phases of clinical research, Performance status, Internal medicine, medicine.medical_specialty, Surgery, Chemoradiotherapy, Temozolomide, Sirolimus, MGMT-Unmethylated Glioblastoma, Population, education.field_of_study, education, business.industry, business, Adult, Aged, Brain Neoplasms/drug therapy, Brain Neoplasms/mortality, Brain Neoplasms/radiotherapy, Chemoradiotherapy/methods, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Dacarbazine/administration & dosage, Dacarbazine/analogs & derivatives, Female, Glioblastoma/drug therapy, Glioblastoma/mortality, Glioblastoma/radiotherapy, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Promoter Regions, Genetic/genetics, Proportional Hazards Models, Sirolimus/administration & dosage, Sirolimus/analogs & derivatives, Tumor Suppressor Proteins/genetics, Young Adult
File Description: application/pdf
Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d7fef0d1608d3697456d8fd4775b80
Authors: Stupp, Roger, Taillibert, Sophie, Kanner, Andrew A, Kesari, Santosh, Steinberg, David M, Toms, Steven A, Taylor, Lynne P, Lieberman, Frank, Silvani, Antonio, Fink, Karen L, Barnett, Gene H, Zhu, Jay-Jiguang, Henson, John W, Engelhard, Herbert H, Chen, Thomas C, Tran, David D, Sroubek, Jan, Tran, Nam D, Hottinger, Andreas F, Landolfi, Joseph, Desai, Rajiv, Caroli, Manuela, Kew, Yvonne, Honnorat, Jerome, Idbaih, Ahmed, Kirson, Eilon D, Weinberg, Uri, Palti, Yoram, Hegi, Monika E, Ram, Zvi
Source:
JAMA, vol. 314, no. 23, pp. 2535-2543
Stupp, Roger; Taillibert, Sophie; Kanner, Andrew A; Kesari, Santosh; Steinberg, David M; Toms, Steven A; Taylor, Lynne P; Lieberman, Frank; Silvani, Antonio; Fink, Karen L; Barnett, Gene H; Zhu, Jay-Jiguang; Henson, John W; Engelhard, Herbert H; Chen, Thomas C; Tran, David D; Sroubek, Jan; Tran, Nam D; Hottinger, Andreas F; Landolfi, Joseph; Desai, Rajiv; Caroli, Manuela; Kew, Yvonne; Honnorat, Jerome; Idbaih, Ahmed; Kirson, Eilon D; Weinberg, Uri; Palti, Yoram; Hegi, Monika E; Ram, Zvi (2015). Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA : the Journal of the American Medical Association, 314(23):2535-2543.
Subject Terms: Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating/therapeutic use, Brain Neoplasms/mortality, Brain Neoplasms/therapy, Canada, Carmustine/therapeutic use, Chemoradiotherapy, Combined Modality Therapy/adverse effects, Combined Modality Therapy/methods, Dacarbazine/analogs & derivatives, Dacarbazine/therapeutic use, Disease Progression, Disease-Free Survival, Early Termination of Clinical Trials, Electric Stimulation Therapy/adverse effects, Electric Stimulation Therapy/methods, Europe, Female, Glioblastoma/mortality, Glioblastoma/therapy, Humans, Israel, Maintenance Chemotherapy/methods, Male, Middle Aged, Republic of Korea, United States, Young Adult, Clinic for Oncology and Hematology, 610 Medicine & health
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::064ddaec257f3c79434d19bf615c0b21
https://serval.unil.ch/notice/serval:BIB_9E83CBEA38DC
Authors: O.W.M. Meyer, Ben J. Slotman, K.H. Njo, A.B.M.F. Karim, A. de Jonge
Contributors: Radiation Oncology, CCA - Cancer biology and immunology, CCA - Treatment and quality of life, Midwifery Science, APH - Quality of Care, Amsterdam Reproduction & Development
Source: Lung Cancer, 10(3-4), 199-208. Elsevier Ireland Ltd
Subject Terms: Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Radiology, medicine.medical_specialty, medicine, Survival analysis, Cancer, medicine.disease, business.industry, business, Combination chemotherapy, Radiation therapy, medicine.medical_treatment, Chemotherapy, Surgery, Respiratory disease, Conventional PCI, Prophylactic cranial irradiation, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Brain Neoplasms/mortality, Carboplatin/administration & dosage, Carcinoma, Small Cell/drug therapy, Chemotherapy, Adjuvant, Combined Modality Therapy, Cranial Irradiation, Cyclophosphamide/administration & dosage, Doxorubicin/administration & dosage, Epirubicin/administration & dosage, Etoposide/administration & dosage, Lomustine/administration & dosage, Lung Neoplasms/drug therapy, Methotrexate/administration & dosage, Remission Induction, Survival Analysis, Thorax/radiation effects, Treatment Outcome, Vincristine/administration & dosage, Carcinoma, Small Cell/drug therapy, Adjuvant
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe937e0decdc8fccf9204c348ffc833
https://api.elsevier.com/content/article/PII:0169500293901806?httpAccept=text/xml
Authors: Roger Stupp, Monika Hegi, Bart Neyns, Roland Goldbrunner, Schlegel, U., Clement, P., Grabenbauer, Gerhard G., Ochsenbein, Adrian F., Matthias Simon, Dietrich, P. Y., Torstena Pietsch, Christine Hicking, Joerg Christian Tonn, Annie-Claire Diserens, Alessia Pica, Mirjam Hermisson, Stefan Krueger, Martine Picard, Michael Weller
Source:
Stupp, R; Hegi, M E; Neyns, B; Goldbrunner, R; Schlegel, U; Clement, P M; Grabenbauer, G G; Ochsenbein, A F; Simon, M; Dietrich, P Y; Pietsch, T; Hicking, C; Tonn, J C; Diserens, A C; Pica, A; Hermisson, M; Krueger, S; Picard, M; Weller, M (2010). Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. Journal of Clinical Oncology, 28(16):2712-2718.
Vrije Universiteit Brussel
Journal of Clinical Oncology, Vol. 28, No 16 (2010) pp. 2712-2718
Subject Terms: Clinic for Neurology, 610 Medicine & health, Cancer Research, Oncology, Maintenance therapy, Internal medicine, medicine.medical_specialty, medicine, business.industry, business, Chemotherapy, medicine.medical_treatment, Concomitant, Cilengitide, chemistry.chemical_compound, chemistry, Surgery, Temozolomide, medicine.drug, Chemoradiotherapy, Radiation therapy, Survival analysis, ddc:616, Adult, Aged, Antineoplastic Agents, Alkylating/administration & dosage/adverse effects, Biopsy, Needle, Brain Neoplasms/*mortality/pathology/*therapy, Combined Modality Therapy, Confidence Intervals, Dacarbazine/administration & dosage/adverse effects/*analogs & derivatives, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Glioblastoma/*mortality/pathology/*therapy, Humans, Immunohistochemistry, Infusions, Intravenous, Kaplan-Meier Estimate, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Recurrence, Local/mortality/pathology, Neoplasm Staging, Neurosurgical Procedures/methods, Probability, Radiotherapy, Adjuvant, Radiotherapy, Conformal, Risk Assessment, Snake Venoms/*administration & dosage/adverse effects, Survival Analysis, Treatment Outcome
File Description: application/pdf
Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e930517abf019ff897b217ffddca638e
Authors: Paul van der Valk, Sieger Leenstra, P. Kaaijk, Peter Sminia, Fabian Fehlauer, Dionisio González González, Lukas J.A. Stalpers, John Panayiotides
Contributors: Cancer Center Amsterdam, Radiotherapy, Pathology, Radiation Oncology, CCA - Cancer biology and immunology, CCA - Treatment and quality of life
Source:
Oncology reports, 11(2), 477-485. Spandidos Publications
Oncology Reports, 11(2), 477-85. Spandidos Publications
Subject Terms: Biomarkers, Tumor/analysis, Brain Neoplasms/mortality, Glioblastoma/mortality, Humans, Organ Culture Techniques, Predictive Value of Tests, Radiosurgery/methods, Radiotherapy/methods, Survival Analysis, Transforming Growth Factor beta/analysis, Tumor Suppressor Protein p53/analysis, Vascular Endothelial Growth Factor A/analysis, Cancer Research, Oncology, General Medicine, Oncogene, Glioma, medicine.disease, medicine, Vascular endothelial growth factor A, Biology, Spheroid, Cancer research, Apoptosis, Cell, medicine.anatomical_structure, Pathology, medicine.medical_specialty, Cell cycle, Cell growth, Biomarkers, Tumor/analysis, embryonic structures
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d523ea10af11fd8c663045edbb5b500b
https://pure.amc.nl/en/publications/effect-of-single-dose-irradiation-on-human-glioblastoma-spheroids-in-vitro(b6ccbde3-b1b1-4960-a4b6-074b913759b1).html
Authors: Diederik W.J. Dippel, Charles J. Vecht, M. J. Van Den Bent, C. J. J. Avezaat, Peter A.E. Sillevis Smitt, T. C. Van Der Ree
Contributors: Erasmus MC: University Medical Center Rotterdam, Department of Neurosurgery, Department of Neurology
Source: Journal of Neurology, Neurosurgery and Psychiatry: an international peer-reviewed journal for health professionals and researchers in all areas of neurology and neurosurgery
Subject Terms: Adult, Aged, Brain Neoplasms/mortality/*secondary/surgery, Female, Humans, Magnetic Resonance Imaging, Male, Meningeal Neoplasms/mortality/pathology/*secondary, Middle Aged, Survival Analysis, Short Report, Psychiatry and Mental health, Clinical Neurology, Surgery, Brain metastasis, medicine.disease, medicine, Cancer, Surgical oncology, medicine.medical_specialty, Metastasis, business.industry, business, Neurooncology, Central nervous system disease, Complication, Craniotomy, medicine.medical_treatment
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0302224b0388507bfc10984acacd4eb0
http://hdl.handle.net/1765/9057
Source: Olsson , A , Bouaoun , L , Auvinen , A , Feychting , M , Johansen , C , Mathiesen , T , Melin , B , Lahkola , A , Larjavaara , S , Villegier , A-S , Byrnes , G , Deltour , I & Schüz , J 2019 , ' Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden ' , Journal of Neuro-Oncology , vol. 141 , no. 1 , pp. 139-149 .
Index Terms: Adolescent, Adult, Aged, Brain Neoplasms/mortality, Case-Control Studies, Cell Phone Use, Denmark/epidemiology, Female, Finland/epidemiology, Glioma/mortality, Humans, Male, Middle Aged, Radio Waves/adverse effects, Sweden/epidemiology, Young Adult, article
Source: Läkartidningen; 107(42), pp 2572-2575 (2010); ISSN: 0023-7205
Index Terms: Pediatrics, Combined Modality Therapy: adverse effects, Brain Neoplasms: complications, Brain Neoplasms: mortality, Neoplasms: complications, Neoplasms: mortality, contributiontojournal/systematicreview, info:eu-repo/semantics/article, text
Source: Journal of neuropathology and experimental neurology, 68 (4
Index Terms: Sciences bio-médicales et agricoles, Brain Neoplasms -- genetics, Brain Neoplasms -- metabolism, Brain Neoplasms -- mortality, Caveolin 1 -- metabolism, Chromosome Deletion, Chromosomes, Human, Pair 1 -- genetics, Female, Follow-Up Studies, Gene Expression Regulation, Neoplastic, Humans, Male, Oligodendroglioma -- genetics, Oligodendroglioma -- metabolism, Oligodendroglioma -- mortality, Retrospective Studies, Survival Analysis, 1p/19q deletion, Caveolin-1, Oligodendroglioma, Survival, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Neuropathology and applied neurobiology, 34 (3
Index Terms: Sciences bio-médicales et agricoles, Adult, Age Factors, Astrocytoma -- metabolism, Astrocytoma -- mortality, Astrocytoma -- pathology, Brain Neoplasms -- metabolism, Brain Neoplasms -- mortality, Brain Neoplasms -- pathology, Child, Female, Humans, Immunohistochemistry, Kaplan-Meiers Estimate, Male, Neoplasm Recurrence, Local -- pathology, Prognosis, Reverse Transcriptase Polymerase Chain Reaction, Spinal Cord Neoplasms -- metabolism, Spinal Cord Neoplasms -- mortality, Spinal Cord Neoplasms -- pathology, Tenascin -- biosynthesis, Tumor Markers, Biological -- analysis, Extracellular matrix, Low-grade astrocytoma, Multivariate analysis, Tenascin-C, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Journal of medicinal chemistry, 49 (5
Index Terms: Sciences bio-médicales et agricoles, Animals, Antineoplastic Agents -- chemical synthesis, Antineoplastic Agents -- chemistry, Antineoplastic Agents -- pharmacology, Brain Neoplasms -- drug therapy, Brain Neoplasms -- mortality, Brain Neoplasms -- pathology, Cell Line, Tumor, Cell Movement -- drug effects, Cisplatin -- pharmacology, Drug Screening Assays, Antitumor, Drug Synergism, Fucose -- chemistry, Glioblastoma -- drug therapy, Glioblastoma -- mortality, Glioblastoma -- pathology, Glycosylation, Humans, Immunocompromised Host, Lactose -- chemistry, Lymphoma -- drug therapy, Lymphoma -- mortality, Lymphoma -- pathology, Mice, Neoplasm Transplantation, Steroids -- chemical synthesis, Steroids -- chemistry, Steroids -- pharmacology, Structure-Activity Relationship, Survival Rate, Transplantation, Heterologous, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: The New England journal of medicine, 352 (10
Index Terms: Sciences bio-médicales et agricoles, Adrenal Cortex Hormones -- therapeutic use, Adult, Aged, Antineoplastic Agents, Alkylating -- adverse effects, Antineoplastic Agents, Alkylating -- therapeutic use, Brain Neoplasms -- drug therapy, Brain Neoplasms -- mortality, Brain Neoplasms -- radiotherapy, Chemotherapy, Adjuvant, Dacarbazine -- adverse effects, Dacarbazine -- analogs & derivatives, Dacarbazine -- therapeutic use, Disease Progression, Female, Glioblastoma -- drug therapy, Glioblastoma -- mortality, Glioblastoma -- radiotherapy, Humans, Male, Middle Aged, Proportional Hazards Models, Radiotherapy, Computer-Assisted -- adverse effects, Survival Analysis, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: International journal of radiation oncology, biology, physics, 60 (1
Index Terms: Cancérologie, Adult, Aged, Aged, 80 and over, Analysis of Variance, Brain Neoplasms -- mortality -- secondary -- surgery, Disease Progression, Female, Humans, Male, Middle Aged, Radiosurgery, Radiotherapy Dosage, Regression Analysis, Survival Analysis, Treatment Outcome, Brain metastases, Stratification, Survival, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Neuro-oncology, 5 (2
Index Terms: Sciences bio-médicales et agricoles, Adult, Aged, Biocompatible Materials -- therapeutic use, Brain Neoplasms -- drug therapy, Brain Neoplasms -- mortality, Brain Neoplasms -- pathology, Brain Neoplasms -- surgery, Carmustine -- therapeutic use, Delayed-Action Preparations -- therapeutic use, Double-Blind Method, Drug Carriers -- therapeutic use, Drug Implants, Female, Glioma -- drug therapy, Glioma -- mortality, Glioma -- pathology, Glioma -- surgery, Humans, Internationality, Male, Middle Aged, Proportional Hazards Models, Prospective Studies, Regression Analysis, Survival Rate, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Neuropathology and applied neurobiology, 26 (1
Index Terms: Sciences bio-médicales et agricoles, Adult, Aged, Aged, 80 and over, Anaplasia, Antigens, Nuclear, Brain Neoplasms -- metabolism, Brain Neoplasms -- mortality, Brain Neoplasms -- pathology, Calcium-Binding Proteins -- analysis, Calcium-Binding Proteins -- biosynthesis, Calcium-Binding Proteins -- immunology, Cell Cycle Proteins, Cell Division, Cerebral Arteries -- chemistry, Cerebral Arteries -- metabolism, Cerebral Arteries -- pathology, Endothelium, Vascular -- chemistry, Endothelium, Vascular -- metabolism, Endothelium, Vascular -- pathology, Female, Glial Fibrillary Acidic Protein -- analysis, Glioblastoma -- metabolism, Glioblastoma -- mortality, Glioblastoma -- pathology, Humans, Male, Middle Aged, Nerve Growth Factors -- analysis, Nerve Growth Factors -- biosynthesis, Nerve Growth Factors -- immunology, Nuclear Proteins -- analysis, Platelet-Derived Growth Factor -- analysis, Proliferating Cell Nuclear Antigen -- analysis, S100 Proteins -- analysis, S100 Proteins -- biosynthesis, S100 Proteins -- immunology, Survival Analysis, Vimentin -- analysis, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Journal of neuro-oncology, 49 (2
Index Terms: Sciences bio-médicales et agricoles, Adolescent, Adult, Aged, Aged, 80 and over, Brain Neoplasms -- mortality, Brain Neoplasms -- radiography, Fluorodeoxyglucose F18 -- diagnostic use, Glioblastoma -- mortality, Glioblastoma -- radiography, Humans, Middle Aged, Neoplasm Staging, Prognosis, Radiopharmaceuticals -- diagnostic use, Survival Rate, Tomography, Emission-Computed -- methods, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Neurosurgery, 39 (3
Index Terms: Sciences bio-médicales et agricoles, Adolescent, Adult, Astrocytoma -- mortality, Astrocytoma -- radionuclide imaging, Astrocytoma -- surgery, Biopsy, Blood Glucose -- metabolism, Brain -- pathology, Brain -- radionuclide imaging, Brain -- surgery, Brain Neoplasms -- mortality, Brain Neoplasms -- radionuclide imaging, Brain Neoplasms -- surgery, Deoxyglucose -- analogs & derivatives, Deoxyglucose -- metabolism, Energy Metabolism -- physiology, Female, Fluorodeoxyglucose F18, Ganglioglioma -- mortality, Ganglioglioma -- radionuclide imaging, Ganglioglioma -- surgery, Glioma -- mortality, Glioma -- radionuclide imaging, Glioma -- surgery, Humans, Male, Middle Aged, Neoplasm Recurrence, Local -- mortality, Neoplasm Recurrence, Local -- radionuclide imaging, Neoplasm Recurrence, Local -- surgery, Oligodendroglioma -- mortality, Oligodendroglioma -- radionuclide imaging, Oligodendroglioma -- surgery, Prognosis, Survival Rate, Tomography, Emission-Computed, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL: